No Data
No Data
The synthetic biology concept opened high and went low. Jiabiyou fell more than 5%, Tebao Biotech and Shengda Biotech fell by more than 4%, and Boen Group and Hanyu Pharmaceutical collectively fell.
The synthetic biology concept opened high and went low. Jiabiyou fell more than 5%, Tebao Biotech and Shengda Biotech fell by more than 4%, and Boen Group and Hanyu Pharmaceutical collectively fell.
Express News | Jia Biyou: The company's daily business situation is normal and there have been no major changes recently
The food processing sector fluctuated and boosted. Jiabiyou surged 13%, Qiaqia Foods rose more than 6%, and Bowling Bao, Sweet Foods, Jinzai Foods, and Hairong Technology followed suit.
The food processing sector fluctuated and boosted. Jiabiyou surged 13%, Qiaqia Foods rose more than 6%, and Bowling Bao, Sweet Foods, Jinzai Foods, and Hairong Technology followed suit.
The synthetic biology concept continued to be strong. Blue Biotech had 3 consecutive sales, Channing Biotech surged 15%, and Langkun Environmental, Fuxiang Pharmaceutical, and Jiabiyou had advanced gains.
The synthetic biology concept continued to be strong. Blue Biotech had 3 consecutive sales, Channing Biotech surged 15%, and Langkun Environmental, Fuxiang Pharmaceutical, and Jiabiyou had advanced gains.
Jia Biyou (688089): Gross margin improved year-on-year in Q1 beyond expectations
Guide to this report: The 24Q1 company's performance exceeded expectations, mainly due to a significant recovery in revenue from overseas customers and a recovery in gross margin. Subsequent major overseas customers and new HMO product expansion are expected to help medium- to long-term growth. Investment Highlights: Investment Suggestions to Consider
Jia Biyou (688089): 23-year results are in line with market expectations, 1Q24 profit margins have recovered
The 23-year results were in line with market expectations, and the 1Q24 performance slightly exceeded market expectations. The company announced 2023&1Q24 results: the company's revenue in 2023 was 404 million yuan, +2.4% year-on-year, and net profit to mother was 91 million yuan
No Data